- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05927714
Palatal Donor Site Wound Healing Following Periodontal Plastic Surgery Using Amnion-Chorion Membrane
September 25, 2023 updated by: Brian L Mealey, The University of Texas Health Science Center at San Antonio
Palatal Donor Site Wound Healing Following Periodontal Plastic Surgery Using Amnion-Chorion Membrane: Site- and Patient-Centered Outcomes
The purpose of this clinical trial is to assess if donor site healing in the palatal area and patient pain perception are similar or different when using amnio-chorion membrane (ACM) on the donor site after surgery compared to a commonly used commercial hemostatic agent (ActCel Cellulose Gauze).
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Resorbable oxidized cellulose materials are commonly used as hemostatic agents in medicine and dentistry.
Surgicel and ActCel are used daily in surgical practice.
When these products come in contact with blood, they convert to a gel that expands to cause direct pressure on blood vessels and control bleeding.
ActCel is water-soluble and dissolves over a short time period.
It can be removed easily when water, saline or hydrogen peroxide is applied.The study team will examine the effects of ACM as a wound dressing for the donor area and compare the rate of epithelialization with and without its use.
Study Type
Interventional
Enrollment (Estimated)
74
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Angela Palaiologou-Gallis, DDS
- Phone Number: 210-567-3567
- Email: palaiologoua@uthscsa.edu
Study Contact Backup
- Name: Brian Mealey, DDS, MS
- Phone Number: 210-450-8736
- Email: mealey@uthscsa.edu
Study Locations
-
-
Texas
-
San Antonio, Texas, United States, 78229
- Recruiting
- University of Texas Health Science Center at San Antonio (Dental School)
-
Contact:
- Brian L Mealey, DDS, MS
- Phone Number: 210-567-3589
- Email: mealey@uthscsa.edu
-
Contact:
- Angela Paiologou-Gallis, DDS
- Phone Number: 210-567-3567
- Email: PalaiologouA@uthscsa.edu
-
Principal Investigator:
- Brian L Mealey, DDS, MS
-
Sub-Investigator:
- Angela Palaiologou-Gallis Palaiologou-Gallis, DDS
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Patients between age 18 and 89
- Patients needing an FSTA in the area of the mouth from 2nd molar to 2nd molar in the maxilla or mandible at sites that have teeth or implants, or in sites that are edentulous
- Patients must be nonsmokers, former smokers, or current smokers who smoke <10 cigarettes per day, by self-report
- Female patients who have undergone a hysterectomy, tubal ligation, or menopause, and non- pregnant women of child-bearing potential.
- Must have access to Smartphone
Exclusion Criteria:
- Patients who disclose that they will not be able to cooperate with the follow-up schedule.
- Patients who are mentally incompetent, prisoners, or pregnant (as obtained via chart review or self-report)
- Pregnant women or women intending to become pregnant during study period
- Smokers who smoke > 10 cigarettes per day
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Use Amnio Chorion Membrane (ACM) with hemostatic agent
ACM or amnion-only membranes have been used in oral surgical procedures primarily because they contain a host of growth factors that play a role in normal wound healing.
|
Amnio-chorion membranes specifically for palatal wound healing following free soft tissue autografts (FTSA) procedures.
Other Names:
When these products come in contact with blood, they convert to a gel that expands to cause direct pressure on blood vessels and control bleeding.
ActCel is water-soluble and dissolves over a short time period.
It can be removed easily when water, saline or hydrogen peroxide is applied.
Other Names:
|
Placebo Comparator: Use of ActCel Cellulose Gauze (Commercial Hemostatic Agent)
Palatal wound dressing with hemostatic agent
|
When these products come in contact with blood, they convert to a gel that expands to cause direct pressure on blood vessels and control bleeding.
ActCel is water-soluble and dissolves over a short time period.
It can be removed easily when water, saline or hydrogen peroxide is applied.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Wound healing time
Time Frame: 1, 2, 3 and 4 weeks post-operatively
|
Change in Area of wound epithelialization will be measured in mm2 at 1, 2, 3 and 4 weeks postoperatively using an Early wound healing index (EHI) index. The index assesses 5 dichotomous variables, each with a "yes" or "no" assessment. "Yes" = score of 1; "No" = score of 2. Total score can range from 5 minimum to 10 maximum. The 5 variables are:
|
1, 2, 3 and 4 weeks post-operatively
|
Post-operative pain
Time Frame: 24, 48 and 72 hours post-surgery
|
Change in pain will be assessed post surgery using a smart-phone application that captures the pain level in a scale of 1-10, where a lower number indicates a less pain
|
24, 48 and 72 hours post-surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Brian Mealey, DDS, MS, University of Texas Health Science Center San Antonio
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 11, 2023
Primary Completion (Estimated)
February 1, 2026
Study Completion (Estimated)
February 1, 2026
Study Registration Dates
First Submitted
June 22, 2023
First Submitted That Met QC Criteria
June 22, 2023
First Posted (Actual)
July 3, 2023
Study Record Updates
Last Update Posted (Actual)
September 26, 2023
Last Update Submitted That Met QC Criteria
September 25, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSC20230345H
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
All collected IPD, all IPD that underlie results in a publication.
IPD will all be deidentified before sharing.
IPD Sharing Time Frame
When summary data are published or otherwise made available when the study is complete.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Palate; Wound
-
Cairo UniversityNot yet recruiting
-
Universidade Estadual Paulista Júlio de Mesquita...RecruitingInsulin | Wound Healing | Palate; WoundBrazil
-
Universidade Estadual Paulista Júlio de Mesquita...RecruitingWound Healing | Palate; WoundBrazil
-
Universitat Internacional de CatalunyaRecruiting
-
Izmir Katip Celebi UniversityCompleted
-
Krishnadevaraya College of Dental Sciences & HospitalCompleted
-
Gazi UniversityCompletedWound Heal | Palate; Wound | Graft Pain
-
Cairo UniversityRecruiting
-
Pamukkale UniversityCompleted
-
University of Sao PauloUnknownPain, Postoperative | Palate; Wound | CicatrizationBrazil
Clinical Trials on Amnion-chorion Membrane
-
Hams Hamed AbdelrahmanRecruiting
-
Harvard Medical School (HMS and HSDM)RecruitingPain, Postoperative | Gingival DiseasesUnited States
-
The University of Texas Health Science Center,...Completed
-
MiMedx Group, Inc.TerminatedPharynx Cancer | Larynx Cancer | Pharyngocutaneous FistulaUnited States
-
MiMedx Group, Inc.TerminatedTreatment of Partial Thickness BurnsUnited States
-
Applied Biologics, LLCUnknownOsteoarthritis, KneeUnited States
-
MiMedx Group, Inc.CompletedKidney Cancer | Partial Nephrectomy | Renal Function AggravatedUnited States
-
Indiana UniversityCompletedPeriodontal DiseasesUnited States
-
University of KentuckyCompleted
-
Cairo UniversityCompleted